Maher Farah, MD - Medicare Hospitalist in Tallassee, AL

Maher Farah, MD is a medicare enrolled "Hospitalist" physician in Tallassee, Alabama. His current practice location is 805 Friendship Rd, Tallassee, Alabama. You can reach out to his office (for appointments etc.) via phone at (334) 283-3753.

Maher Farah is licensed to practice in Alabama (license number 22724) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1558442194.

Contact Information

Maher Farah, MD
805 Friendship Rd,
Tallassee, AL 36078-1234
(334) 283-3753
(334) 283-3758



Physician's Profile

Full NameMaher Farah
GenderMale
SpecialityHospitalist
Location805 Friendship Rd, Tallassee, Alabama
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1558442194
  • Provider Enumeration Date: 10/18/2006
  • Last Update Date: 02/01/2013
  Medicare PECOS Information:
  • PECOS PAC ID: 3072658863
  • Enrollment ID: I20100304000384

Medical Identifiers

Medical identifiers for Maher Farah such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1558442194NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208M00000XHospitalist 22724 (Alabama)Primary
208M00000XHospitalist 14373 (Nevada)Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Maher Farah allows following entities to bill medicare on his behalf.
Entity NameJackson Hospital And Clinic, Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073264107
PECOS PAC ID: 0547254153
Enrollment ID: O20040414000971

News Archive

Global health programs need to address community needs

A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help - or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.

Loyola's Murali Rao achieves Distinguished Life Fellow status

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

Anavex files regulatory submission in Germany for ANAVEX 2-73 Phase I trial in Alzheimer's disease

Anavex Life Sciences Corp. announced today that it has filed the regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease.

Better architectural design could stop suicide among young people

Suicide among younger people is often so spontaneous that it can be prevented if they do not encounter a potentially dangerous place outdoors. Getting the form of the built environment correct is therefore a very important factor in stopping suicide among young people.

Ranbaxy to appeal injunction against sales of Quinapril

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the U.S. District Court for the District of New Jersey hearing the preliminary injunction motion brought by Pfizer against Teva Pharmaceuticals USA, Inc. (Teva) and Ranbaxy Pharmaceuticals Inc. (RPI) enjoined Teva and RPI from selling RPI's quinapril tablets (5, 10, 20, and 40 mg).

Read more Medical News

› Verified 4 days ago

Entity NameCommunity Hospital Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295040376
PECOS PAC ID: 2062408487
Enrollment ID: O20040421001819

News Archive

Global health programs need to address community needs

A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help - or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.

Loyola's Murali Rao achieves Distinguished Life Fellow status

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

Anavex files regulatory submission in Germany for ANAVEX 2-73 Phase I trial in Alzheimer's disease

Anavex Life Sciences Corp. announced today that it has filed the regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease.

Better architectural design could stop suicide among young people

Suicide among younger people is often so spontaneous that it can be prevented if they do not encounter a potentially dangerous place outdoors. Getting the form of the built environment correct is therefore a very important factor in stopping suicide among young people.

Ranbaxy to appeal injunction against sales of Quinapril

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the U.S. District Court for the District of New Jersey hearing the preliminary injunction motion brought by Pfizer against Teva Pharmaceuticals USA, Inc. (Teva) and Ranbaxy Pharmaceuticals Inc. (RPI) enjoined Teva and RPI from selling RPI's quinapril tablets (5, 10, 20, and 40 mg).

Read more Medical News

› Verified 4 days ago

Entity NameJackson Montgomery Emergency Physcians, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952358590
PECOS PAC ID: 5597785634
Enrollment ID: O20051202000795

News Archive

Global health programs need to address community needs

A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help - or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.

Loyola's Murali Rao achieves Distinguished Life Fellow status

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

Anavex files regulatory submission in Germany for ANAVEX 2-73 Phase I trial in Alzheimer's disease

Anavex Life Sciences Corp. announced today that it has filed the regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease.

Better architectural design could stop suicide among young people

Suicide among younger people is often so spontaneous that it can be prevented if they do not encounter a potentially dangerous place outdoors. Getting the form of the built environment correct is therefore a very important factor in stopping suicide among young people.

Ranbaxy to appeal injunction against sales of Quinapril

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the U.S. District Court for the District of New Jersey hearing the preliminary injunction motion brought by Pfizer against Teva Pharmaceuticals USA, Inc. (Teva) and Ranbaxy Pharmaceuticals Inc. (RPI) enjoined Teva and RPI from selling RPI's quinapril tablets (5, 10, 20, and 40 mg).

Read more Medical News

› Verified 4 days ago

Entity NameNes Tennessee, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1437606605
PECOS PAC ID: 3678472040
Enrollment ID: O20161031002328

News Archive

Global health programs need to address community needs

A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help - or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.

Loyola's Murali Rao achieves Distinguished Life Fellow status

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

Anavex files regulatory submission in Germany for ANAVEX 2-73 Phase I trial in Alzheimer's disease

Anavex Life Sciences Corp. announced today that it has filed the regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease.

Better architectural design could stop suicide among young people

Suicide among younger people is often so spontaneous that it can be prevented if they do not encounter a potentially dangerous place outdoors. Getting the form of the built environment correct is therefore a very important factor in stopping suicide among young people.

Ranbaxy to appeal injunction against sales of Quinapril

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the U.S. District Court for the District of New Jersey hearing the preliminary injunction motion brought by Pfizer against Teva Pharmaceuticals USA, Inc. (Teva) and Ranbaxy Pharmaceuticals Inc. (RPI) enjoined Teva and RPI from selling RPI's quinapril tablets (5, 10, 20, and 40 mg).

Read more Medical News

› Verified 4 days ago

Entity NameIntegrated Care-alabama Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215572888
PECOS PAC ID: 8224462833
Enrollment ID: O20200107000485

News Archive

Global health programs need to address community needs

A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help - or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.

Loyola's Murali Rao achieves Distinguished Life Fellow status

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

Anavex files regulatory submission in Germany for ANAVEX 2-73 Phase I trial in Alzheimer's disease

Anavex Life Sciences Corp. announced today that it has filed the regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease.

Better architectural design could stop suicide among young people

Suicide among younger people is often so spontaneous that it can be prevented if they do not encounter a potentially dangerous place outdoors. Getting the form of the built environment correct is therefore a very important factor in stopping suicide among young people.

Ranbaxy to appeal injunction against sales of Quinapril

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the U.S. District Court for the District of New Jersey hearing the preliminary injunction motion brought by Pfizer against Teva Pharmaceuticals USA, Inc. (Teva) and Ranbaxy Pharmaceuticals Inc. (RPI) enjoined Teva and RPI from selling RPI's quinapril tablets (5, 10, 20, and 40 mg).

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Maher Farah is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Maher Farah, MD
9533 Fendall Hall Cir,
Montgomery, AL 36117-8519

Ph: (334) 202-7258
Maher Farah, MD
805 Friendship Rd,
Tallassee, AL 36078-1234

Ph: (334) 283-3753

News Archive

Global health programs need to address community needs

A "key problem" in reaching the goal of polio elimination "may well be that organizers of the global anti-polio initiative, and of other global health programs, are not listening to the people they want to help - or to each other," Thomas Abraham, an associate professor in the Journalism and Media Studies Center at the University of Hong Kong, writes in a New York Times opinion piece.

Loyola's Murali Rao achieves Distinguished Life Fellow status

Loyola University Medical Center psychiatrist Murali Rao, MD, has achieved Distinguished Life Fellow status in the American Psychiatric Association, the highest honor the profession can bestow.

Anavex files regulatory submission in Germany for ANAVEX 2-73 Phase I trial in Alzheimer's disease

Anavex Life Sciences Corp. announced today that it has filed the regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease.

Better architectural design could stop suicide among young people

Suicide among younger people is often so spontaneous that it can be prevented if they do not encounter a potentially dangerous place outdoors. Getting the form of the built environment correct is therefore a very important factor in stopping suicide among young people.

Ranbaxy to appeal injunction against sales of Quinapril

Ranbaxy Laboratories Limited (Ranbaxy) announced today that the U.S. District Court for the District of New Jersey hearing the preliminary injunction motion brought by Pfizer against Teva Pharmaceuticals USA, Inc. (Teva) and Ranbaxy Pharmaceuticals Inc. (RPI) enjoined Teva and RPI from selling RPI's quinapril tablets (5, 10, 20, and 40 mg).

Read more News

› Verified 4 days ago


Hospitalist Doctors in Tallassee, AL


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.